Medanta Breaks Out On High Volumes; SEBI RAs Eye ₹1,375–₹1,380 Upside

Global Health, the company behind the Medanta hospital chain, is drawing attention from technical analysts after a sharp surge and breakout on strong volumes. 

SEBI-registered analyst Sameer Pande observed signs of a positive reversal forming on the monthly chart, supported by a healthy relative strength index (RSI) reading around 65. 

On the daily chart, he pointed to a breakout above the supertrend line, with RSI nearing 70. 

According to him, ₹1,300 is a key level to watch, and a clean move above it could open the path to ₹1,380. He suggested that traders consider buying above ₹1,300 or look for entries closer to the ₹1,230–₹1,200 demand zone, with a stop-loss set at ₹1,180 on a closing basis.

Meanwhile, SEBI-registered analyst Vijay Kumar Gupta noted that the stock has broken out of a long consolidation zone, with a notable rise in volume. 

He identified ₹1,229–₹1,230 as a zone that had acted as resistance, and is now likely to act as support. 

Gupta said that a hold above ₹1,230–₹1,220 would be a sign of strength, while deeper support lies at ₹1,150–₹1,160 and further down at ₹1,050–₹1,030. His strategy includes watching for a pullback near ₹1,230–₹1,220 for a potential bounce, or adding above ₹1,300 if the move is backed by strong volume. 

He said a breakout beyond ₹1,300 could take the stock toward ₹1,350–₹1,375. 

At the same time, he flagged ₹1,220 as a key level and said if the stock fails to hold it, traders should be cautious and monitor the lower support areas.

On Stocktwits, retail sentiment for Global Health was ‘extremely bullish’ amid ‘extremely high’ message volume.

The stock has risen 17.7% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.